Ratio of angiopoietin-2 to Angiopoietin-1 predicts mortality in acute lung injury induced by paraquat

Medical Science Monitor

Volumn 19, Issue 1, 2013, Pages 28-33

  Choi, Jae Sung ^a   Kwak, Kyung A ^a   Park, Min Ju ^a   Kim, Young Hee ^a   Gil, Hyo Wook ^a   Song, Ho yeon ^a   Hong, Sae Yong ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Acute lung injury; Angiopoietin; Endothelial cells; Paraquat

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; BICARBONATE; CREATININE; VON WILLEBRAND FACTOR;

ACUTE LUNG INJURY; ADULT; AGE; ARTICLE; BLOOD CARBON DIOXIDE TENSION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG LESION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARAQUAT POISONING; PROSPECTIVE STUDY; SURVIVOR;

EID: 84876829316     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883730     Document Type: Article

References (31)

1. Pittet J, Mackersie R, Martin T et al: Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med, 1997; 155(4): 1187-205
2. Giuliano Jr JS, Lahni PM, Harmon K et al: Admission angiopoietin levels in children with septic shock. Shock, 2007; 28(6): 650-54
3. Orfanos SE, Kotanidou A, Glynos C et al: Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med, 2007; 35(1): 199-206
4. Gallagher DC, Parikh SM, Balonov K et al: Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock, 2008; 29(6): 656-61
5. Ganter MT, Cohen MJ, Brohi K et al: Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma? Ann Surg, 2008; 247(2): 320-26
6. Giamarellos-Bourboulis EJ, Kanellakopoulou K, Pelekanou A et al: Kinetics of angiopoietin-2 in serum of multi-trauma patients: correlation with patient severity. Cytokine, 2008; 44(2): 310-13
7. Kumpers P, Lukasz A, David S et al: Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care, 2008; 12(6): R147
8. Siner JM, Bhandari V, Engle KM et al: Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock, 2009; 31(4): 348-53
9. van der Heijden M, van Nieuw Amerongen GP, Koolwijk P et al: Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax, 2008; 63(10): 903-9
10. Ong T, McClintock DE, Kallet RH et al: Ratio of angiopoietin-2 to angiopoietin- 1 as a predictor of mortality in acute lung injury patients. Crit Care Med, 2010; 38(9): 1845-51
11. Ricciuto DR, Dos Santos CC, Hawkes M et al: Angiopoietin-1 and angiopoietin- 2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med, 2011; 39(4): 702-10
12. Parikh SM, Mammoto T, Schultz A et al: Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Medicine, 2006; 3(3): 356-70
13. Eklund L, Olsen BR: Tie receptors and their angiopoietin ligands are contextdependent regulators of vascular remodeling. Exp Cell Res, 2006; 312(5): 630-41
14. Thurston G, Rudge JS, Ioffe E et al: Angiopoietin-1 protects the adult vasculature against plasma leakage. Nature medicine, 2000; 6(4): 460-63
15. Kwak HJ, Lee SJ, Lee YH et al: Angiopoietin-1 inhibits irradiation-and mannitol- induced apoptosis in endothelial cells. Circulation, 2000; 101(19): 2317-24
16. Simoes D, Vassilakopoulos T, Toumpanakis D et al: Angiopoietin-1 protects against airway inflammation and hyperreactivity in asthma. Am J Respir Crit Care Med, 2008; 177: 1314-21
17. Tabruyn S, Colton K, Morisada T et al: Angiopoietin-2-driven vascular remodeling in airway inflammation. Am J Pathol, 2010; 177: 3233-43
18. Calfee CS, Gallagher D, Abbott J et al, The NHLBI ARDS Network: Plasma angiopoietin- 2 in clinical acute lung injury: Prognostic and pathogenetic significance. Crit Care Med, 2012; 40(6): 1731-37
19. Koutsostathis S, Tsaganos T, Lallos S et al: Early increase of serum angiopoietin- 2 are associated with early progression to death in experimental injury. Cytokine, 2011; 56(3): 817-22
20. Bhandari V, Choo-Wing R, Harijith A et al: Increased hyperoxia-induced lung injury in nitric oxide synthase 2 null mice is mediated via angiopoietin 2. Am J Respir Cell Mol Biol, 2012; 46(5): 668-76
21. Ribes JA, Francis CW, Wagner DD: Fibrin induces release of von Willebrand factor from endothelial cells. J Clin Invest, 1987; 79(1): 117-23
22. Ware LB, Conner ER, Matthay MA: von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med, 2001; 29(12): 2325-31
23. Ware LB, Eisner MD, Thompson BT et al: Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med, 2004; 170: 766-72
24. Bus JS, Gibson JE: Paraquat: model for oxidant-initiated toxicity. Environ Health Perspect, 1984; 55: 37-46
25. Delaval PM, Gillespie DJ: Pulmonary dysfunction during paraquat-induced lung injury: A model of acute alveolar injury. Crit Care Med, 1985; 13(12): 1056-60
26. Webb D, Williams M, Davies B et al: Resolution after radiotherapy of severe pulmonary damage due to paraquat poisoning. Br Med J (Clin Res Ed), 1984; 288: 1259-60
27. Zou Y, Shi Y, Bai Y et al: An improved approach for extraction and high-performance liquid chromatography analysis of paraquat in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci, 2011; 879(20): 1809-12
28. Rose MS, Smith LL, Wyatt I: Evidence for energy-dependent accumulation of paraquat into rat lung. Nature, 1974; 252: 314-15
29. Vale J, Meredith T, Buckley B: Paraquat poisoning: clinical features and immediate general management. Hum Toxicol, 1987; 6(1): 41-47
30. Moss M, Ackerson L, Gillespie MK et al: von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome. Am J Respir Crit Care Med, 1995; 151: 15-20
31. Sabharwal AK, Bajaj SP, Ameri A et al: Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am J Respir Crit Care Med, 1995; 151(3): 758-67